marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Plus Therapeutics Financial Ratios 2011-2024 | PSTV
Annual Financial Ratios Plus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.0 | -0.8 | -1.3 | -0.3 | -0.2 | -0.6 | -1.2 | -1.5 | -1.1 | -7.2 | -5.7 | -6.0 |
P/S |
- | - | - | 35.0 | 0.4 | 0.4 | 2.2 | 2.4 | 2.4 | 5.4 | 15.5 | 12.7 | 24.2 |
EPS |
-4.2 | -11.6 | -1.1 | -1.9 | -8.3 | -87.0 | -411.6 | -1.3 | -2.1 | -0.5 | -0.4 | -0.6 | -0.6 |
EV (Enterprise Value) |
11.2 M | -15.4 K | 4.11 M | 11.3 M | 7.58 M | 16.2 M | 23.3 M | 38.5 M | 39.2 M | 70.5 M | 212 M | 196 M | 198 M |
EBITDA per Share |
-4.04 | -10.9 | -1 | -1.92 | -1.99 | -66 | -300 | -536 | -1.11 K | -2.83 K | -3.34 K | -3.33 K | -4.39 K |
EV/EBITDA |
0.6 | -1.1 | 1.2 | -1.0 | -0.9 | -1.8 | -1.5 | -1.6 | -6.3 | -6.6 | -5.5 | ||
PEG |
-0.0 | -0.0 | 0.02 | -0.05 | -0.0 | -0.0 | -0.02 | -0.03 | -0.02 | 0.05 | -0.25 | -0.58 | 3.57 |
P/B |
-5.2 | 0.1 | 1.0 | 3.5 | 2.6 | 0.5 | 1.1 | 2.5 | 2.3 | -7.1 | 60.2 | 28.6 | 19.4 |
P/CF |
-0.5 | -0.1 | -1.1 | -1.2 | -0.5 | -0.2 | -0.7 | -1.4 | -1.3 | -1.3 | -5.4 | -5.5 | -5.4 |
ROE % |
987.83 | -314.58 | -123.65 | -271.89 | -938.53 | -241.80 | -174.51 | -200.67 | -153.56 | 655.35 | -835.79 | -500.06 | -326.27 |
ROA % |
-116.93 | -84.95 | -60.96 | -68.08 | -46.87 | -52.66 | -71.76 | -63.70 | -49.72 | -96.51 | -62.24 | -74.63 | -62.97 |
ROCE % |
988.20 | -305.85 | -115.28 | -246.86 | -41.83 | -197.42 | -156.68 | -89.14 | -78.45 | -143.87 | -122.81 | -110.34 | -77.26 |
Current Ratio |
0.9 | 1.4 | 2.0 | 1.1 | 1.4 | 0.5 | 0.8 | 1.5 | 2.5 | 1.4 | 1.6 | 1.9 | 5.5 |
DSO |
- | - | - | 71.1 | 68.5 | 20.7 | 14.6 | 41.5 | 41.1 | 65.3 | 127.6 | 101.6 | 103.3 |
DIO |
- | - | - | - | - | 937.0 | 881.5 | 500.8 | 492.4 | 599.5 | 394.1 | 289.7 | 315.6 |
DPO |
- | - | - | 336038506.4 | - | 228.9 | 359.2 | 179.1 | 115.6 | 117.8 | 103.0 | 144.1 | 25.9 |
Operating Cycle |
- | - | - | 71.1 | - | 957.7 | 896.1 | 542.3 | 533.5 | 664.9 | 521.7 | 391.3 | 419.0 |
Cash Conversion Cycle |
- | - | - | -336038435.3 | - | 728.7 | 536.9 | 363.2 | 417.9 | 547.0 | 418.8 | 247.2 | 393.1 |
All numbers in USD currency
Quarterly Financial Ratios Plus Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -0.45 | -0.75 | - | -1 | -0.59 | -2.07 | - | -2.85 | -3.56 | -0.19 | - | -0.28 | -0.25 | -0.33 | - | -0.39 | -0.45 | -0.28 | - | -0.03 | -20.67 | -8.92 | - | -27.63 | -29.67 | -36.63 | -0.2 | -1.39 | -1.94 | -0.33 | -0.24 | -0.26 | -0.43 | -0.41 | -0.25 | 0.15 | 0.48 | -3.19 | -0.08 | -0.12 | -0.15 | -0.14 | -0.14 | -0.08 | -0.05 | -0.11 | -0.06 | -0.19 | -0.13 | -0.16 | -0.13 | -0.15 | -0.1 | -0.23 |
EBITDA per Share |
- | - | -0.73 | - | - | - | -1.97 | - | -2.53 | -3.45 | -0.18 | - | -0.24 | -0.21 | -0.29 | - | -0.26 | -0.53 | -0.6 | - | 4.18 | -3.03 | -4.88 | - | -4.37 | -7.06 | -19.7 | - | -0.79 | -1.45 | -0.29 | - | -0.2 | -0.38 | -0.37 | - | 0.27 | 0.68 | -2.94 | - | -0.09 | -0.13 | -0.13 | - | -0.11 | -0.08 | -0.1 | - | -0.16 | -0.11 | -0.14 | - | -0.13 | -0.08 | -0.2 |
ROE % |
38.75 | -139.56 | -233.79 | -358.00 | -403.76 | -326.76 | -325.66 | -128.45 | -153.69 | -133.16 | -102.03 | -77.27 | -134.28 | -166.05 | -203.29 | -153.55 | -108.20 | -5.85 | -733.71 | -1014.74 | -1059.33 | -1149.27 | -430.77 | -199.00 | -231.97 | -224.36 | -200.86 | -174.51 | -186.30 | -198.34 | -210.11 | -200.67 | -178.49 | -117.03 | -22.28 | -153.56 | -30.06 | 122.08 | 293.07 | 655.35 | 233.83 | -98.65 | -408.60 | -835.79 | -574.42 | -580.80 | -600.40 | -500.06 | -510.27 | -419.82 | -349.36 | -326.27 | -83.80 | -51.66 | -121.38 |
ROA % |
-149.67 | -132.72 | -116.94 | -65.41 | -88.00 | -86.34 | -100.74 | -64.21 | -79.26 | -71.71 | -60.32 | -40.86 | -55.14 | -54.36 | -56.12 | -38.45 | -36.18 | -19.64 | -43.83 | -50.67 | -60.39 | -72.36 | -48.24 | -43.34 | -56.90 | -62.39 | -66.27 | -71.76 | -72.41 | -72.76 | -72.14 | -63.70 | -56.80 | -37.21 | -6.90 | -49.72 | -57.27 | -85.55 | -127.90 | -96.51 | -105.52 | -93.78 | -70.87 | -62.24 | -47.20 | -60.71 | -71.30 | -74.63 | -79.20 | -69.36 | -61.11 | -62.97 | -16.17 | -9.97 | -23.43 |
ROCE % |
66.12 | -131.29 | -235.75 | -356.42 | -401.09 | -321.77 | -318.69 | -124.38 | -148.09 | -127.14 | -95.80 | -71.33 | -117.39 | -139.73 | -195.77 | -204.19 | 26.84 | 303.94 | 212.66 | -124.57 | -167.19 | -440.85 | -307.30 | -132.88 | -166.29 | -157.07 | -164.67 | -131.18 | -174.84 | -185.10 | -198.82 | -146.71 | -130.35 | -70.33 | 33.78 | -108.21 | 30.16 | 152.18 | 292.11 | 493.20 | 223.05 | -185.47 | -576.02 | -688.41 | -848.47 | -738.39 | -643.05 | -397.47 | -476.13 | -394.72 | -330.86 | -235.65 | -78.65 | -43.96 | -113.04 |
Current Ratio |
0.6 | 0.6 | 0.5 | 0.9 | 1.2 | 1.2 | 1.2 | 1.4 | 2.0 | 1.8 | 2.5 | 2.0 | 2.5 | 2.3 | 2.0 | 1.3 | 1.3 | 1.3 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.7 | 1.7 | 1.7 | 1.7 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0.9 | 0.9 | 0.9 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.4 | - | 18.9 | 32.1 | 26.0 | 18.9 | 28.3 | 13.7 | 107.1 | 77.3 | 155.0 | 100.7 | 78.5 | 61.7 | 125.3 | 59.5 | 116.1 | 45.9 | 219.0 | 121.3 | 238.8 | 140.0 | 234.4 | 269.1 | 264.8 | 90.3 | 272.6 | 184.0 | 190.6 | 99.3 | 96.6 | 85.5 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.4 | - | 18.9 | 32.1 | 26.0 | 18.9 | 28.3 | 13.7 | 107.1 | 77.3 | 155.0 | 100.7 | 78.5 | 61.7 | 125.3 | 59.5 | 116.1 | 45.9 | 219.0 | 121.3 | 238.8 | 140.0 | 234.4 | 269.1 | 264.8 | 90.3 | 272.6 | 184.0 | 190.6 | 99.3 | 96.6 | 85.5 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.4 | - | 18.9 | 32.1 | 26.0 | 18.9 | 28.3 | 13.7 | 107.1 | 77.3 | 155.0 | 100.7 | 78.5 | 61.7 | 125.3 | 59.5 | 116.1 | 45.9 | 219.0 | 121.3 | 238.8 | 140.0 | 234.4 | 269.1 | 264.8 | 90.3 | 272.6 | 184.0 | 190.6 | 99.3 | 96.6 | 85.5 | - |
All numbers in USD currency